永吉股份(603058) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 224,351,811.57, representing a year-on-year increase of 29.04%[4] - The net profit attributable to shareholders for the same period was CNY 40,493,153.35, reflecting a growth of 31.02% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 41,409,014.63, which is an increase of 33.65% year-on-year[4] - The basic earnings per share for Q1 2024 was CNY 0.097, up by 34.72% from the same period last year[4] - The diluted earnings per share was CNY 0.096, showing a growth of 33.33% year-on-year[4] - Net profit for Q1 2024 reached CNY 43,358,592.94, representing a 43.5% increase from CNY 30,202,186.00 in Q1 2023[19] - The total comprehensive income for Q1 2024 was CNY 34,539,654.73, compared to CNY 26,494,899.22 in Q1 2023, indicating a growth of 30.5%[20] Cash Flow and Investments - The net cash flow from operating activities was negative at CNY -22,290,910.07, a decrease of 409.87% compared to the previous year[4] - The net cash flow from operating activities for Q1 2024 was negative CNY 22,290,910.07, a decline from a positive CNY 7,193,699.34 in Q1 2023[23] - In Q1 2024, the net cash flow from investing activities was -$39.27 million, compared to $114.79 million in the previous period[24] - The total cash inflow from financing activities was $20 million, while the cash outflow was $16.8 million, resulting in a net cash flow of $3.2 million[24] - The net increase in cash and cash equivalents for the period was -$58.75 million, down from an increase of $119.71 million in the previous year[24] - The ending balance of cash and cash equivalents was $101.46 million, significantly lower than $376.18 million at the end of the previous period[24] - The company received $20 million in cash from borrowings during the financing activities[24] - Cash paid for debt repayment was $15.1 million, slightly higher than $14.8 million in the previous period[24] Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,923,381,742.45, a slight increase of 0.78% from the end of the previous year[5] - Total current assets as of March 31, 2024, amounted to CNY 793,040,102.16, up from CNY 765,179,311.66 at the end of 2023, reflecting a growth of 3.7%[14] - Accounts receivable increased to CNY 341,939,666.18 from CNY 281,968,554.96, representing a rise of 21.3%[14] - Non-current assets totaled CNY 1,130,341,640.29, a decrease of 1.1% from CNY 1,143,330,013.85 at the end of 2023[15] - Total liabilities decreased to CNY 685,486,073.90 from CNY 707,104,021.83, a reduction of 3.1%[16] - The company's cash and cash equivalents decreased to CNY 120,658,463.94 from CNY 178,893,448.06, a decline of 32.5%[14] - Short-term borrowings increased to CNY 40,000,000.00 from CNY 20,000,000.00, marking a 100% increase[15] - The company's retained earnings rose to CNY 437,008,725.14 from CNY 396,515,571.79, an increase of 10.2%[16] Operating Costs and Expenses - Total operating costs for Q1 2024 were CNY 167,438,104.72, an increase of 20.2% compared to CNY 139,355,496.58 in Q1 2023[19] - Research and development expenses for Q1 2024 were CNY 9,081,124.25, slightly down from CNY 9,202,666.51 in Q1 2023[19] - The tax expenses for Q1 2024 were CNY 7,484,293.97, an increase from CNY 5,679,584.44 in Q1 2023[19] - The company incurred a net investment loss of CNY 616,168.42 in Q1 2024, a significant improvement from a loss of CNY 504,436.89 in Q1 2023[19] - Non-recurring losses totaled CNY -915,861.28, primarily due to losses from financial assets and other operating expenses[6] Revenue Sources - The company attributed the revenue growth primarily to significant increases in overseas medical cannabis sales and new customers for cigarette labels outside the province[7] - Revenue from sales of goods and services in Q1 2024 was CNY 181,235,983.10, down 18.8% from CNY 223,218,263.76 in Q1 2023[23] Other Information - Cash dividends proposed for 2023 are CNY 0.8 per 10 shares, subject to approval at the annual shareholders' meeting[11] - The company did not apply new accounting standards or interpretations for the first time in 2024[24] - The weighted average return on net assets was 3.72%, an increase of 0.82% compared to the previous year[5] - Other comprehensive income after tax for Q1 2024 was negative CNY 8,818,938.21, worsening from negative CNY 3,707,286.78 in Q1 2023[20]